Stocks Up; Will This Biotech Be The Best Growth Play in 2H 2017?


Can Vertex Pharmaceuticals emerge as one of the hottest growth stocks in the second half of this year? So far, the Boston-based biotech has been sharply outperforming the market in June, and its earnings outlook is robust. The Nasdaq composite looked headed toward a weekly gain of nearly 2% as it dominated the other key indexes in late-afternoon trade Friday.



from Biotech News